Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 97 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| DRD5 | ENSG00000169676 | 0.00 | 0.00 | 0 | 0 |
| BUB1 | ENSG00000169679 | 0.00 | 0.00 | 0 | 0 |
| CHRNA5 | ENSG00000169684 | 0.12 | 0.00 | 1 | 0 |
| GP9 | ENSG00000169704 | 0.00 | 0.00 | 0 | 0 |
| DCXR | ENSG00000169738 | 0.84 | 0.11 | 4 | 1 |
| NRG4 | ENSG00000169752 | 0.12 | 0.00 | 1 | 0 |
| TAS2R1 | ENSG00000169777 | 0.00 | 0.00 | 0 | 0 |
| TACR3 | ENSG00000169836 | 0.00 | 0.00 | 0 | 0 |
| P2RY1 | ENSG00000169860 | 0.00 | 0.00 | 0 | 0 |
| MUC17 | ENSG00000169876 | 0.00 | 0.00 | 0 | 0 |
| MUC3A | ENSG00000169894 | 0.00 | 0.00 | 0 | 0 |
| TM4SF1 | ENSG00000169908 | 0.00 | 0.00 | 0 | 0 |
| TAS1R3 | ENSG00000169962 | 0.00 | 0.00 | 0 | 0 |
| NLGN2 | ENSG00000169992 | 0.00 | 0.15 | 0 | 1 |
| YWHAG | ENSG00000170027 | 0.00 | 0.00 | 0 | 0 |
| KCNAB3 | ENSG00000170049 | 0.00 | 0.00 | 0 | 0 |
| SERPINA9 | ENSG00000170054 | 0.00 | 0.00 | 0 | 0 |
| SERPINA6 | ENSG00000170099 | 0.00 | 0.00 | 0 | 0 |
| GPR25 | ENSG00000170128 | 0.00 | 0.00 | 0 | 0 |
| GYPA | ENSG00000170180 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 97 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.